Mr Willard M Woods Jr, MD | |
1551 Brice St, Wheatland, WY 82201-3505 | |
(307) 322-3861 | |
(307) 322-2018 |
Full Name | Mr Willard M Woods Jr |
---|---|
Gender | Male |
Speciality | Obstetrics & Gynecology - Gynecology |
Location | 1551 Brice St, Wheatland, Wyoming |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1457352452 | NPI | - | NPPES |
301617 | Other | WY | WY BC/BS |
10223000 | Medicaid | WY |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207VG0400X | Obstetrics & Gynecology - Gynecology | 2725A (Wyoming) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mr Willard M Woods Jr, MD 1551 Brice St, Wheatland, WY 82201-3505 Ph: (307) 322-3861 | Mr Willard M Woods Jr, MD 1551 Brice St, Wheatland, WY 82201-3505 Ph: (307) 322-3861 |
News Archive
Billions of dollars have been spent on developing drugs and supplying them around the world, but which companies' drugs are actually making an impact? The Global Health Impact Index, headed by Binghamton University Associate Professor Nicole Hassoun and highlighted in a new article published Friday in PLOS ONE, addresses this issue by ranking pharmaceutical companies based on their drugs' impact on global health.
Safeguard Scientifics, Inc., a holding company that builds value in growth-stage life sciences and technology companies, announced that Risk Metrics Group (RMG), an advisor to institutional investors on corporate governance and risk management issues, issued recommendations to its institutional clients regarding proposals to be considered at Safeguard's annual meeting of shareholders.
Cancer Research UK scientists have discovered how two genes can 'hijack' control of part of the body's defences against cancer, helping them grow and spread.
A drug that targets the immune system can delay the onset of type 1 diabetes an average of two years in children and adults at high risk, according to findings from TrialNet's Teplizumab (anti-CD3) Prevention Study published in the New England Journal of Medicine.
Broken bones among older people increase their risk of death for up to 10 years, according to a new study published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism.
› Verified 3 days ago